Related Experiment Video

Updated: Oct 11, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

515

Endothelial dysfunction and COVID-19: What's the true impact on surrogate outcomes?

Dimitrios Patoulias1, Christodoulos Papadopoulos2, Michael Doumas3

  • 1Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece.

International Journal of Cardiology
|December 2, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.9K

Related Experiment Videos

Last Updated: Oct 11, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

515
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.1K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.9K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

475
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
475
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

78
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
78

Articles linked to this work by shared authors, journal, and citation graph.

Chronic Kidney Disease-Associated Cardiomyopathy: Mechanisms and Therapeutic Strategies.

British journal of hospital medicine (London, England : 2005)·2026

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

JAMA·2026

True Left Bundle Branch Block by Strauss Criteria: Impact on CRT Response and Conduction System Pacing Trial Design-A Systematic Evidence Synthesis Toward Personalized Patient Selection.

Journal of personalized medicine·2026

Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry.

Acta cardiologica·2026

Obese and overweight patients with type 2 diabetes mellitus are not treated optimally - an overview of current clinical practice and future perspectives.

Expert review of clinical pharmacology·2026

Atrial Fibrillation in Diabetes: Epidemiology, Mechanisms and Integrated Management.

Journal of clinical medicine·2026

Diabetes-associated diffuse myocardial fibrosis assessed by native T1 mapping: Adverse cardiac phenotype and modest incremental prognostic value in a real-world cohort.

International journal of cardiology·2026

Temporal trends in initial rhythms of out-of-hospital cardiac arrest in an aging society: a nationwide analysis from Japan.

International journal of cardiology·2026

Glycaemic variation and atrial fibrillation burden and progression in individuals without diabetes undergoing continuous rhythm monitoring.

International journal of cardiology·2026

Myocardial remodeling and fibrosis by cardiovascular magnetic resonance in adults with congenital aortic valve stenosis.

International journal of cardiology·2026

Imaging signatures of high-risk arrhythmogenic genotypes in dilated cardiomyopathy.

International journal of cardiology·2026

Impact of variant reclassification on genetic testing yield and clinical outlook in patients with hypertrophic cardiomyopathy.

International journal of cardiology·2026

Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.

Rheumatology (Oxford, England)·2026

Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.

The British journal of radiology·2026

Myocardial Calcification After Severe Sepsis: 3-Patient Case Series, Multimodality Imaging, and Review of the Literature.

JACC. Case reports·2026

One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.

Molecular medicine reports·2026

BIOCARD framework: integrating fecal bile acids, lipids, and metabolites to assess response to a cardiovascular health intervention.

Gut microbes·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us